Zobrazeno 1 - 10 of 14 pro vyhledávání: '"Madeline Waldron"'
2
Clonal dynamics of aplastic anemia/paroxysmal nocturnal hemoglobinuria
Autor: Madeline Waldron, Hetty E. Carraway, Shimoli V. Barot, Bhumika J. Patel, Alok Vij, Jaroslaw P. Maciejewski, Steven D. Billings, Mikkael A. Sekeres
Publikováno v: Leuk Lymphoma
Acquired aplastic anemia (AA) is a bone marrow failure disorder caused by immune mediated destruction of hematopoietic progenitor cells. Despite excellent response rates and survival with immunosup...
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d33daa75bdaac4ad69b7999a3c3817d
https://doi.org/10.1080/10428194.2019.1706734
Zobrazit plný text záznamu
3
A Phase I/II Trial of CPX-351 + Palbociclib in Patients with Acute Myeloid Leukemia
Autor: Jenna Thomas, Mikkael A. Sekeres, Hetty E. Carraway, Caitlin Siebenaller, Madeline Waldron, Eric Parsons, Sudipto Mukherjee, Yihong Guan, Aziz Nazha, Anjali S. Advani, Dale Grabowski, Bhumika J. Patel, Jaroslaw P. Maciejewski, Aaron T. Gerds
Publikováno v: Blood. 136:13-14
Background Cytarabine resistance is a major reason for compromised treatment efficacy in acute myeloid leukemia (AML). This may be due to leukemic cells being at different stages in their cell cycle, with some at G0/G1, others in M phase, and only a
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a8bbafcc1e808ffd99fea3d9e563847f
https://doi.org/10.1182/blood-2020-139494
Zobrazit plný text záznamu
4
A Phase II Study of CPX-351 As a Novel Therapeutic Approach for Patients with Myelodysplastic Syndromes (MDS) after Hypomethylating Agent Failure
Autor: Hetty E. Carraway, Sudipto Mukherjee, Madeline Waldron, Eric Parsons, Anjali S. Advani, Aziz Nazha, Bhumika J. Patel, Jenna Thomas, Mikkael A. Sekeres, Caitlin Siebenaller, Aaron T. Gerds
Publikováno v: Blood. 136:1-1
Treatment options are limited for patients (pts) diagnosed with MDS at the time of hypomethylating agent (HMA) failure. One goal is to introduce another line of therapy to reduce tumor burden and enable patients to undergo hematopoietic stem cell tra
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::47aa786f0cd5f3b9c35b829ff8af4830
https://doi.org/10.1182/blood-2020-139515
Zobrazit plný text záznamu
5
Itraconazole vs. posaconazole for antifungal prophylaxis in patients with acute myeloid leukemia undergoing intensive chemotherapy: A retrospective study
Autor: Kyle D. Brizendine, Madeline Waldron, Caitlin Siebenaller, Vasilios Athans, Sarah Welch, Eric Cober, Melissa S. Copley
Publikováno v: International Journal of Antimicrobial Agents. 55:105886
The objective of this study was to compare itraconazole with posaconazole for antifungal prophylaxis in acute myeloid leukemia (AML) patients undergoing intensive chemotherapy.Adult patients with AML received either itraconazole or posaconazole for a
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06b00b7131dde40397ea4aaf49787ad1
https://doi.org/10.1016/j.ijantimicag.2020.105886
Zobrazit plný text záznamu
6
Initiation of venovenous extracorporeal membrane oxygenation in a patient receiving induction chemotherapy for acute myelogenous leukemia
Autor: Madeline Waldron, Sudipto Mukherjee, Sameer K. Avasarala, Anita J. Reddy, Muhammad Raheel Qureshi
Publikováno v: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners. 25(6)
BackgroundAcute respiratory failure is a leading cause of intensive care unit admission in patients with hematological malignancies; it carries a mortality rate exceeding 50%. Venovenous extracorporeal membrane oxygenation use in patients with acute
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68dd7a0fe20d13da46304aef9f823b6e
https://pubmed.ncbi.nlm.nih.gov/30041582
Zobrazit plný text záznamu
8
Pharmacokinetic and Pharmacodynamic Considerations in the Treatment of Chronic Lymphocytic Leukemia: Ibrutinib, Idelalisib, and Venetoclax
Autor: Allison M. Winter, Madeline Waldron, Brian T. Hill
Publikováno v: Clinical pharmacokinetics. 56(11)
Management of chronic lymphocytic leukemia has changed markedly over the last several years with the emergence of several novel oral agents targeting B-cell receptor and Bcl-2 signaling pathways. For patients requiring treatment, ibrutinib, idelalisi
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d9ed13e4474b1ae34aba343f6dec4411
https://pubmed.ncbi.nlm.nih.gov/28343293
Zobrazit plný text záznamu
10
Impact of Venous Thromboembolism during High Intensity Chemotherapy for Acute Leukemia Patients on Duration of Hospital Stay
Autor: Xuefei Jia, Caitlin Siebenaller, Sudipto Mukherjee, Matt Kalaycio, Madeline Waldron, Hetty E. Carraway, Ronald Sobecks, Betty K. Hamilton, Aaron T. Gerds, Barb Tripp, Mikkael A. Sekeres, Anjali S. Advani, Aziz Nazha, Brian P. Hobbs, Marc Earl
Publikováno v: Blood. 132:4806-4806
Background: Patients (pts) with hematologic malignancies have an increased risk of venous thromboembolism (VTE) events, driven by both the underlying cancer and cancer treatment. This risk exists even in acute leukemia (AL) in the setting of profound
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::755454e1be2fe1b3cb26ce2327ca94ad
https://doi.org/10.1182/blood-2018-99-115257
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje